910904-64-2 Usage
Uses
Used in Neurodegenerative Disease Treatment:
2-PyriMidinaMine, 5-nitro-N-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]is used as a selective M1 muscarinic receptor agonist for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's. It helps improve cognitive function and memory by activating specific receptors in the brain.
Used in Cognitive Enhancement:
2-PyriMidinaMine, 5-nitro-N-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]is used as a cognitive enhancer to improve memory and cognitive function in individuals with neurodegenerative diseases or other cognitive impairments.
Used in Motor Control Aid:
2-PyriMidinaMine, 5-nitro-N-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]is used as a motor control aid to assist individuals with movement disorders or motor impairments associated with neurodegenerative diseases.
Used in Schizophrenia Treatment:
2-PyriMidinaMine, 5-nitro-N-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]is used as a therapeutic agent for the treatment of schizophrenia, potentially improving cognitive and behavioral symptoms.
Used in Drug Addiction Treatment:
2-PyriMidinaMine, 5-nitro-N-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]is used as a therapeutic agent for the treatment of drug addiction, potentially aiding in the reduction of cravings and relapse prevention.
Check Digit Verification of cas no
The CAS Registry Mumber 910904-64-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,0,9,0 and 4 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 910904-64:
(8*9)+(7*1)+(6*0)+(5*9)+(4*0)+(3*4)+(2*6)+(1*4)=152
152 % 10 = 2
So 910904-64-2 is a valid CAS Registry Number.
910904-64-2Relevant academic research and scientific papers
2-AMINO-5-SUBSTITUTED PYRIMIDINE INHIBITORS
-
Page/Page column 61-62, (2010/11/29)
Compounds having the general structure (A) are provided. The compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, Vegfr and various other specific receptor and non-receptor kinases. Formula (I):
PYRIMIDINE COMPOUNDS AND METHODS OF USE
-
Page/Page column 54; 88-89, (2010/11/24)
The invention provides pyrimidine compounds having formula (A): The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, and various other specific receptor and non-receptor kinases.
